When aged care becomes a short stay
As people look after themselves at home and go into care older, they "stay" for shorter periods. That is undermining the business model of aged care providers like Estia.
As people look after themselves at home and go into care older, they "stay" for shorter periods. That is undermining the business model of aged care providers like Estia.
Sigma Pharmaceuticals is well placed to capitalise on growth opportunities, according to broker UBS, which has upgraded the company to a "buy."
Estia Health's sale of apartments to its CFO Steven Boggiano is (another) bad look for the embattled aged-care service provider.
Low-cost gym operator Jetts Fitness is shaping up to be the third leg of Quadrant Private Equity's push into Australia's fragmented health, fitness and wellness industries.
Sigma Pharmaceuticals chief executive Mark Hooper estimates the government has spent about $1 billion subsidising new hepatitis C drugs in the past five months, but says the "unprecedented" cost is worth it.
Sigma Pharmaceuticals expects full-year earnings growth of 10 per cent after lifting its half-year net profit by 25 per cent.
Macquarie is the latest to cut price targets on aged care operators Estia Health, Japara Health and Regis Healthcare.
Estia Health has sold off apartments at big discounts and one of the buyers was its own CFO.
The head of Bupa's Australasian business Dean Holden will be replaced by Bupa UK managing director Richard Bowden.
The carnage in the listed aged care sector over the past week - as wary investors were spooked by government curbs on federal funding - has ...
Unlimited access to business news and market insights across any device
Already a subscriber? Log in